Epidermodysplasia verruciformis;Epidermodisplasia verruciforme

Actas Dermo-Sifiliograficas

Volumn 96, Issue 8, 2005, Pages 531-533

  Sánchez García, Virginia P ^a   Sanz, Andrés ^a   Eloy, Carmen ^a   Vera, Ángel ^a   Martín, Trinidad ^a   Sánchez Fajardo, Francisco ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Epidermodysplasia verruciformis; HPV 5; HPV 8; Human papillomavirus

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HISPANIC; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; IMMUNOCOMPETENCE; KERATINOCYTE; MOLECULAR BIOLOGY; PRURITUS; SKIN DISEASE; VIRUS ISOLATION; WART VIRUS;

EID: 29044436273     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(05)73127-6     Document Type: Article

References (13)

1. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol. 1995;131:1312-8.
2. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997;36:659-85.
3. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol. 1994;186:157-75.
4. Majewski S, Skopinska-Rosewska E, Jablonska S, Wasik M, Misiewick J, Orth G. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol. 1986;15:966-73.
5. Davison SC, Francis N, McLean K, Bunker CB. Epidermodysplasia verruciformis-like eruption associated with HIV infection. Clin Exp Dermatol. 2004;29:311-24.
6. Tobin E, Rohwedder A, Holland SM, Phillips B, Carlson JA. Recurrent «sterile» verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia. Br J Dermatol. 2003; 149:627-33.
7. Barzegar C, Paul C, Saiag P. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol. 1998;139:122-7.
8. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis: genetic and virologic studies of a kindred. Arch Dermatol. 1985;121:864-8.
9. Ramoz N, Taieb A, Rueda LA. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol. 2000;114:1148-53.
10. De Oliveira WR, Rady PL, Grady J, et al. Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol. 2003;49:639-43.
11. Jablonska S, Majewski S. Epidermodysplasia Verruciformis: what's new? J Eur Acad Derm Venereol. 2003;17:381-2.
12. De Oliveira WR, Neto CF, Rivitti EA. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. JEADV. 2004;50:e14.
13. Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, Gürgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol. 2001;45:296-9.